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Necroptosis has emerged as an important facet of both host defense and inflammatory disease. In this issue,
Rodrigue-Gervais et al. (2014) demonstrate a role for the cell death regulator cIAP2 in maintaining lung
homeostasis during influenza infection. Loss of cIAP2 promotes necroptosis of lung tissues, leading to
host death.Programmed cell death is critical to tis-
sue homeostasis, immunity, and host
defense. Apoptosis is the most well
studied of the cell death pathways and
is the ordered dismantling of cells due
to the activation of cysteine-dependent
proteases known as caspases. Apical
caspases, such as caspase-8 and
caspase-9, process and activate effector
caspases, including caspase-3 and
caspase-7, which direct the proteolytic
processing of the cell, resulting in char-
acteristic DNA fragmentation and mem-
brane blebbing. In addition to apoptosis,
it is now appreciated that other forms
of controlled death like programmed
necrosis and pyroptosis contribute
significantly to these ends. Like apo-
ptosis, pyroptosis requires the activity
of caspases, but is associated with the
maturation of proinflammatory cytokines
and results in the loss of plasma mem-
brane integrity. In addition, programmed
necrosis, or necroptosis, is an emerg-
ing caspase-independent cell death
pathway involved in a wide spectrum of
inflammatory conditions and an impor-
tant component of host defense (Mori-
waki and Chan, 2013). Apoptosis and
necroptosis share many of the same initi-
ating stimuli, effectors, and regulators.
Death ligands, such as Fas ligand
(FasL), tumor necrosis factor (TNF), and
TNF-related apoptosis-inducing ligand
(TRAIL), as well as pattern recognition
receptors (PRRs) and genotoxic stresses
(Vanlangenakker et al., 2012), initiate
signal transduction pathways that can
lead to either apoptosis or necroptosis.
The choice of the specific death pathway
is influenced by relative levels of cellular
regulators, such as caspases. For
example, in many cases, necroptosis is
activated when caspase-8 activity isabsent or inhibited. It has also emerged
that the receptor-interacting protein ki-
nase (RIPK, also known as RIP) 3, along
with RIPK1 in the case of death recep-
tors, play a central role in necroptotic
signaling, and knockdown or genetic
deletion of RIPK3 abolishes programmed
necrosis from a variety of death signals
(Moriwaki and Chan, 2013).
As decisions to live or die have rather
permanent consequences, these path-
ways are tightly regulated by multiple
molecules. Among those, cellular
FLICE-like inhibitor protein (cFLIP) is a
potent inhibitor of apoptosis. Encoding
both long (L) and short (S) isoforms,
cFLIP acts by inhibiting caspase activity.
Interestingly, cFLIPS inhibition of cas-
pase-8 sensitizes cells to necroptosis,
while cFLIPL has been shown to inhibit
this pathway, demonstrating the complex
interplay between apoptotic and necrop-
totic pathways. Another family of pro-
teins, the cellular inhibitor of apoptosis
proteins (cIAPs), are also essential for
control of both apoptosis and necropto-
sis (Silke and Meier, 2013). IAPs function
as E3 ubiquitin ligases, mediating the
transfer of ubiquitin onto target sub-
strates, and are best known as important
regulators of apoptotic caspases. cIAPs
also regulate the formation of a large
macromolecular signaling complex
known as the ripoptosome (Bertrand
and Vandenabeele, 2011) that controls
the cellular decision to undergo
apoptosis or necroptosis. While com-
bined genetic loss of cIAP1/cIAP2 or
XIAP/cIAP2 results in embryonic lethality
due to RIPK3-dependent necroptosis
(Moulin et al., 2012), functional redun-
dancy among IAPs has made discerning
the bona fide contributions of individual
IAPs difficult.Cell Host & MicrobeIn recent years, an increasing number
of viral pathogens have been shown to
induce or modulate necroptosis to influ-
ence virulence and pathogenesis (Mocar-
ski et al., 2012). Like apoptosis, necropto-
sis can serve as an effective host defense
mechanism enabling clearance of the
pathogen, but can also lead to tissue
injury and disease pathology. Both
apoptosis and necrosis have been impli-
cated in influenza A virus (IAV) infection
(Yatim and Albert, 2011), highlighting the
complex relationship between IAV and
cell death programs. Given the high de-
gree of crosstalk between these path-
ways, it becomes crucial to understand
the specific context under which a partic-
ular death program is executed, and how
it influences pathogenesis.
In this issue of Cell Host & Microbe,
Rodrigue-Gervais and colleagues report
that cIAP2 promotes host survival during
IAV infection by preventing necroptosis
of lung epithelial cells (Rodrigue-Gervais
et al., 2014). Wild-type (WT) mice infected
with a sublethal dose of mouse-adapted
H1N1 virus became sick, but eventually
recovered from the infection. However,
cIAP2-deficient (Birc3/) mice suc-
cumbed to infection at substantially
higher rates, despite no significant in-
creases in viral titers, inflammatory cyto-
kines, or immune cell recruitment to the
infected lungs. Moreover, Birc3/ mice
produced functional IAV antigen-specific
CD8+ T cells at levels comparable to
WT mice. Using bone marrow chimeras,
the authors demonstrated that a nonhe-
matopoietic cellular reservoir required
cIAP2 during IAV infection to prevent
death. In support of this, histological ex-
amination of IAV-infected Birc3/ mice
showed significant inflammation and
hemorrhaging, as well as epithelial15, January 15, 2014 ª2014 Elsevier Inc. 3
Figure 1. Proposed Model for the Role of cIAP2 in Influenza
Pathogenesis
In influenza A virus (IAV)-infected wild-typemice, Fas signaling initiates forma-
tion of a RIPK1-FADD-caspase-8 (Casp8) ripoptosome, leading to apoptosis
of airway epithelial cells. cIAP2 activity prevents RIPK3 incorporation to the
complex, inhibiting necroptosis. Apoptosis leaves the airway barrier intact,
and infected mice survive and clear IAV infection. In cIAP2-deficient (Birc3/)
mice, airway epithelial cells are primed with preformed ripoptosomes, and
enhanced levels of cFLIPS inhibit apoptosis. Fas signaling results in RIPK3
incorporation into the ripotosome. The ensuing necroptosis destroys airway
epithelia, leading to death of the host. Blue, red, green: wild-type, Birc3/,
and IAV-infected epithelial cells, respectively.
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integrity when compared to
WT mice.
Having established a genu-
ine biological role for cIAP2
during influenza infection,
Rodrigue-Gervais and col-
leagues turned to investigate
the mechanism behind the
significant tissue destruction
in infected cIAP2-deficient
mice. Quantitative PCR of
infected lungs revealed that
Birc3/ mice expressed
higher levels of FasL, TNF,
and TRAIL than WT controls,
suggesting a role for these
molecules during infection
and implicating apoptosis
as a potential mechanism.
However, multiple lines of
histological and biochemical
evidence indicated reduced
levels of caspase activation
during infection. Indeed,
airway epithelial cells isolated
from WT and Birc3/ mice
showed similar overall levels
of cell death, but Birc3/
animals demonstrated signif-
icantly less caspase activa-tion, suggesting that apoptosis was not
responsible for the phenotype. Addition-
ally, potential roles for the inflammasome
or pyroptosis in influenza-induced lung
cell death were excluded. Instead, inhibi-
tion of necroptosis, via chemical inhibition
of RIPK1 activity or genetic deletion of
RIP3, ameliorated lung pathology and en-
hanced Birc3/ mouse survival during
IAV infection. Biochemical investigations
revealed that loss of cIAP2 correlated
with changes in cFLIP isoform expression
and promoted the spontaneous formation
of the ripoptosome in Birc3/ mouse
lung homogenates. When infected with
IAV, enhanced recruitment of RIP3 to
the ripoptosome complex was detected.
Thus, the authors clearly implicate
RIPK1/RIPK3 necroptosis as the execu-
tioner of death during IAV infection in the
absence of cIAP2 function. Finally, they
bring it full circle to implicate death cyto-
kines in the initiation of IAV-induced
necroptosis. Transfer of FasL/, or to a
lesser extent TRAIL/, bone marrow to
irradiated Birc3/ mice protected them
from IAV-induced lethality, while TNF
and the related cytokine lymphotoxin A4 Cell Host & Microbe 15, January 15, 2014 ªshowed no effect. Interestingly, compari-
sons between infected and uninfected
cells from lungs of WT or Birc3/ mice
indicated that uninfected cells were as
likely to die as infected ones, but levels
of necrosis were much higher in Birc3/
mice.
From these results, a model develops
(Figure 1) wherein IAV infection induces
FasL (and/or TRAIL) upregulation in
hematopoietic cells, which are recruited
to infected lungs. In WT mice, these cells
induce apoptosis of infected and unin-
fected cells, which are both effectively
cleared. However, in mice lacking cIAP2,
or those treated with IAP antagonists,
airway endothelial cells are ‘‘primed’’ for
necrosis by preformed ripoptosomes,
which recruit RIP3 and initiate necroptosis
downstream of Fas signaling. Importantly,
this necrosis is not antiviral, is not due to
viral cytopathic effect, and likely influ-
ences bystander epithelial cells dispro-
portionately. This results in widespread
tissue destruction and host mortality.
A number of questions arise from
the results reported by Rodrigue-Gervais
and colleagues, among them whether2014 Elsevier Inc.this phenotype is specific to
cIAP2. Currently, prevailing
thought is that many functions
of IAP proteins are redundant.
Do other IAPs play a similar
role in balancing necroptosis
and apoptosis during influ-
enza and other viral infections,
and would Birc2/ mice
respond similarly? Or do
certain IAPs function in spe-
cific tissues, or in response
to different pathogens? Per-
haps a more pressing ques-
tion is whether these results
will hold in human influenza
patients. Do individual differ-
ences in cIAP2, or environ-
mental conditions limiting
cIAP2 function, underlie indi-
vidual susceptibility to lethal
IAV infection? In addition
to cell death and inflammation,
IAPs are involved in regulating
a variety of other cellular
processes, including proli-
feration, differentiation, and
motility (Gyrd-Hansen and
Meier, 2010). Since many of
these processes are deregu-
lated in cancers, IAPs havebeen targeted for anticancer therapies.
Small-molecule antagonists of IAPs, also
known as Smac-mimetics (SM), have
been developed and are in clinical trials
for treatment of a variety of tumors
(Gyrd-Hansen and Meier, 2010). In light
of the results presented (Rodrigue-Ger-
vais et al., 2014), it is urgently needed to
determine if the treatment of cancer
patients with IAP antagonists increases
their risk of catching a fatal case of the
flu. If so, this could provide yet another
potential clinical application of chemical
inhibitors of necroptosis.
The results presented by Rodrigue-
Gervais et al. in this issue of Cell Host &
Microbe highlight a dramatic contribution
of necroptosis to the pathology of IAV
andpotentially other respiratory infections.
It also provides yet another example of
how host genetics and environment
could influence morbidity and mortality.
Increasing threats from highly pathogenic
IAV strains have already prompted con-
sideration of host responses for targeted
treatments in addition to purely antiviral
therapies to mitigate the severity of dis-
ease (D’Elia et al., 2013). Now, the role of
Cell Host & Microbe
PreviewscIAP2 and necroptosis should enter that
discussion, and these avenues could
potentially lead tobetterpatient outcomes.
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The densemicrobial ecosystemwithin the gut is connected through a complexweb ofmetabolic interactions.
In this issue of Cell Host & Microbe, Degnan et al. (2014) establish the importance of different vitamin
B12 transporters that help a Bacteroides species acquire vitamins from the environment to maintain a
competitive edge.The intestinal microbiota has rapidly
become one of the most intensely
studied microbial ecosystems on the
planet, yet much of its biology remains
unexplored (Gordon, 2012; Proctor,
2011). Insights into the genomic under-
pinnings of adaptation and the molecular
mechanisms employed by model micro-
bial communities living within gnotobiotic
mice have begun to illuminate what life is
like for microbes within the gut (Qin
et al., 2010; Sonnenburg et al., 2010).
However, much of this research has
focused on the primary economy of gut
residents, the conversion of carbohy-
drates into fermentation products like
short-chain fatty acids (Fischbach and
Sonnenburg, 2011; Koropatkin et al.,
2012). Some studies have furthered our
understanding of these main metabolic
thoroughfares by investigating the con-
sumption of these ‘‘end-products’’ by
other microbial scavengers (Rey et al.,
2013). The metabolic flow of the primary
sources of carbon and energy and the
dynamics they dictate within the microbi-
al ecosystem serve as important funda-
mental principles. However, it is clear
that many poorly understood facetsof microbiota metabolism occurring on
adjacent pathways are equally important.
Even with bountiful carbohydrates,
whether a microbe can successfully
acquire essential cofactors can mean
the difference between life and death.
In this issue, Degnan et al. (2014) delve
into the dizzying set of transporters en-
coded within the microbiome for the
acquisition of vitamin B12 analogs known
as corrinoids (Degnan et al., 2014). Over
20 corrinoids have been defined to date
and, although not entirely functionally
equivalent to one another, many substi-
tute as cofactors to the same enzymes
(Yi et al., 2012). By surveying over 300
sequenced microbiota-derived bacterial
genomes, the authors show that at least
83% of sequenced strains surveyed
possess enzymes that are dependent on
vitamin B12. De novo biosynthesis of
corrinoids takes a staggering number of
enzymatic steps (30), so it is not sur-
prising that only a small set of gut
microbes produce these molecules, while
the remainder scavenge them from other
microbes or the host’s diet. These find-
ings highlight a ‘‘corrinoid economy’’
within the gut, in which these compoundsrepresent a form of currency that is
highly valued and exchanged between
microbes.
In performing the genomic analysis, the
authors recognized that many strains
possess multiple genes encoding corri-
noid transporters, some up to four copies.
Yet it was unclear why such apparent
redundancy within a single genome was
necessary. This study focused on Bacter-
oides thetaiotaomicron, a genetically
tractable and common member of the
human microbiota that encodes three
B12-acquisition systems. Knockouts of
all pairwise combinations of the outer
membrane, corrinoid-transporter genes
(named btuB1, btuB2, and btuB3)
enabled a single transporter to be studied
in isolation. Using thesemutants in culture
competition assays with a precious panel
of chemically synthesized corrinoids that
differ in one variable structural motif,
known as the lower ligand, the authors
demonstrate that each corrinoid trans-
porter is differentially competent in B12
transport and specializes in a specific
subset of structurally distinct corrinoids.
Extending these competitions to a gnoto-
biotic mouse gut, the authors corroborate15, January 15, 2014 ª2014 Elsevier Inc. 5
